Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning
• Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added.
Gespeichert in:
| Autor*in: |
Gadducci, Angiolo [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
Insulin-like growth factor [IGF] AMP-activated protein kinase [AMPK] |
|---|
| Umfang: |
11 |
|---|
| Übergeordnetes Werk: |
Enthalten in: miR-214 in stroma cells and tumor progression - Dettori, D. ELSEVIER, 2016, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:105 ; year:2016 ; pages:73-83 ; extent:11 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.critrevonc.2016.06.006 |
|---|
| Katalog-ID: |
ELV040154548 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV040154548 | ||
| 003 | DE-627 | ||
| 005 | 20230624071144.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.critrevonc.2016.06.006 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016018000014.pica |
| 035 | |a (DE-627)ELV040154548 | ||
| 035 | |a (ELSEVIER)S1040-8428(16)30139-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.52 |2 bkl | ||
| 100 | 1 | |a Gadducci, Angiolo |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning |
| 264 | 1 | |c 2016 | |
| 300 | |a 11 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added. | ||
| 650 | 7 | |a Endometrial cancer |2 Elsevier | |
| 650 | 7 | |a Chemoprevention |2 Elsevier | |
| 650 | 7 | |a Insulin-like growth factor [IGF] |2 Elsevier | |
| 650 | 7 | |a AMP-activated protein kinase [AMPK] |2 Elsevier | |
| 650 | 7 | |a Mammalian target of rapamycin [mTOR] |2 Elsevier | |
| 650 | 7 | |a Breast cancer |2 Elsevier | |
| 650 | 7 | |a Metformin |2 Elsevier | |
| 650 | 7 | |a Diabetes |2 Elsevier | |
| 650 | 7 | |a Insulin |2 Elsevier | |
| 650 | 7 | |a Ovarian cancer |2 Elsevier | |
| 700 | 1 | |a Biglia, Nicoletta |4 oth | |
| 700 | 1 | |a Tana, Roberta |4 oth | |
| 700 | 1 | |a Cosio, Stefania |4 oth | |
| 700 | 1 | |a Gallo, Martina |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Dettori, D. ELSEVIER |t miR-214 in stroma cells and tumor progression |d 2016 |g Amsterdam [u.a.] |w (DE-627)ELV019637179 |
| 773 | 1 | 8 | |g volume:105 |g year:2016 |g pages:73-83 |g extent:11 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.critrevonc.2016.06.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a GBV_ILN_11 | ||
| 912 | |a GBV_ILN_20 | ||
| 912 | |a GBV_ILN_70 | ||
| 912 | |a GBV_ILN_100 | ||
| 912 | |a GBV_ILN_2006 | ||
| 912 | |a GBV_ILN_2009 | ||
| 912 | |a GBV_ILN_2014 | ||
| 912 | |a GBV_ILN_2015 | ||
| 912 | |a GBV_ILN_2016 | ||
| 912 | |a GBV_ILN_2048 | ||
| 936 | b | k | |a 44.52 |j Therapie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 105 |j 2016 |h 73-83 |g 11 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
a g ag |
|---|---|
| matchkey_str |
gadducciangiolobiglianicolettatanarobert:2016----:efriuengnclgclacraoetetetpinmri |
| hierarchy_sort_str |
2016 |
| bklnumber |
44.52 |
| publishDate |
2016 |
| allfields |
10.1016/j.critrevonc.2016.06.006 doi GBVA2016018000014.pica (DE-627)ELV040154548 (ELSEVIER)S1040-8428(16)30139-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Gadducci, Angiolo verfasserin aut Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning 2016 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added. Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer Elsevier Biglia, Nicoletta oth Tana, Roberta oth Cosio, Stefania oth Gallo, Martina oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:105 year:2016 pages:73-83 extent:11 https://doi.org/10.1016/j.critrevonc.2016.06.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 105 2016 73-83 11 045F 610 |
| spelling |
10.1016/j.critrevonc.2016.06.006 doi GBVA2016018000014.pica (DE-627)ELV040154548 (ELSEVIER)S1040-8428(16)30139-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Gadducci, Angiolo verfasserin aut Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning 2016 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added. Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer Elsevier Biglia, Nicoletta oth Tana, Roberta oth Cosio, Stefania oth Gallo, Martina oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:105 year:2016 pages:73-83 extent:11 https://doi.org/10.1016/j.critrevonc.2016.06.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 105 2016 73-83 11 045F 610 |
| allfields_unstemmed |
10.1016/j.critrevonc.2016.06.006 doi GBVA2016018000014.pica (DE-627)ELV040154548 (ELSEVIER)S1040-8428(16)30139-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Gadducci, Angiolo verfasserin aut Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning 2016 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added. Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer Elsevier Biglia, Nicoletta oth Tana, Roberta oth Cosio, Stefania oth Gallo, Martina oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:105 year:2016 pages:73-83 extent:11 https://doi.org/10.1016/j.critrevonc.2016.06.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 105 2016 73-83 11 045F 610 |
| allfieldsGer |
10.1016/j.critrevonc.2016.06.006 doi GBVA2016018000014.pica (DE-627)ELV040154548 (ELSEVIER)S1040-8428(16)30139-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Gadducci, Angiolo verfasserin aut Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning 2016 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added. Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer Elsevier Biglia, Nicoletta oth Tana, Roberta oth Cosio, Stefania oth Gallo, Martina oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:105 year:2016 pages:73-83 extent:11 https://doi.org/10.1016/j.critrevonc.2016.06.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 105 2016 73-83 11 045F 610 |
| allfieldsSound |
10.1016/j.critrevonc.2016.06.006 doi GBVA2016018000014.pica (DE-627)ELV040154548 (ELSEVIER)S1040-8428(16)30139-1 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 610 VZ 44.52 bkl Gadducci, Angiolo verfasserin aut Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning 2016 11 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added. Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer Elsevier Biglia, Nicoletta oth Tana, Roberta oth Cosio, Stefania oth Gallo, Martina oth Enthalten in Elsevier Science Dettori, D. ELSEVIER miR-214 in stroma cells and tumor progression 2016 Amsterdam [u.a.] (DE-627)ELV019637179 volume:105 year:2016 pages:73-83 extent:11 https://doi.org/10.1016/j.critrevonc.2016.06.006 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 44.52 Therapie Medizin VZ AR 105 2016 73-83 11 045F 610 |
| language |
English |
| source |
Enthalten in miR-214 in stroma cells and tumor progression Amsterdam [u.a.] volume:105 year:2016 pages:73-83 extent:11 |
| sourceStr |
Enthalten in miR-214 in stroma cells and tumor progression Amsterdam [u.a.] volume:105 year:2016 pages:73-83 extent:11 |
| format_phy_str_mv |
Article |
| bklname |
Therapie |
| institution |
findex.gbv.de |
| topic_facet |
Endometrial cancer Chemoprevention Insulin-like growth factor [IGF] AMP-activated protein kinase [AMPK] Mammalian target of rapamycin [mTOR] Breast cancer Metformin Diabetes Insulin Ovarian cancer |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
miR-214 in stroma cells and tumor progression |
| authorswithroles_txt_mv |
Gadducci, Angiolo @@aut@@ Biglia, Nicoletta @@oth@@ Tana, Roberta @@oth@@ Cosio, Stefania @@oth@@ Gallo, Martina @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV019637179 |
| dewey-sort |
3610 |
| id |
ELV040154548 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV040154548</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624071144.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.critrevonc.2016.06.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV040154548</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1040-8428(16)30139-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gadducci, Angiolo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Endometrial cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemoprevention</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Insulin-like growth factor [IGF]</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AMP-activated protein kinase [AMPK]</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Mammalian target of rapamycin [mTOR]</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metformin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diabetes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Insulin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ovarian cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Biglia, Nicoletta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tana, Roberta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cosio, Stefania</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gallo, Martina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Dettori, D. ELSEVIER</subfield><subfield code="t">miR-214 in stroma cells and tumor progression</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV019637179</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:105</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:73-83</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.critrevonc.2016.06.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2016</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">105</subfield><subfield code="j">2016</subfield><subfield code="h">73-83</subfield><subfield code="g">11</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Gadducci, Angiolo |
| spellingShingle |
Gadducci, Angiolo ddc 610 bkl 44.52 Elsevier Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning |
| authorStr |
Gadducci, Angiolo |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV019637179 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.52 bkl Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer Elsevier |
| topic |
ddc 610 bkl 44.52 Elsevier Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer |
| topic_unstemmed |
ddc 610 bkl 44.52 Elsevier Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer |
| topic_browse |
ddc 610 bkl 44.52 Elsevier Endometrial cancer Elsevier Chemoprevention Elsevier Insulin-like growth factor [IGF] Elsevier AMP-activated protein kinase [AMPK] Elsevier Mammalian target of rapamycin [mTOR] Elsevier Breast cancer Elsevier Metformin Elsevier Diabetes Elsevier Insulin Elsevier Ovarian cancer |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
n b nb r t rt s c sc m g mg |
| hierarchy_parent_title |
miR-214 in stroma cells and tumor progression |
| hierarchy_parent_id |
ELV019637179 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
miR-214 in stroma cells and tumor progression |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV019637179 |
| title |
Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning |
| ctrlnum |
(DE-627)ELV040154548 (ELSEVIER)S1040-8428(16)30139-1 |
| title_full |
Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning |
| author_sort |
Gadducci, Angiolo |
| journal |
miR-214 in stroma cells and tumor progression |
| journalStr |
miR-214 in stroma cells and tumor progression |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
73 |
| author_browse |
Gadducci, Angiolo |
| container_volume |
105 |
| physical |
11 |
| class |
610 610 DE-600 610 VZ 44.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Gadducci, Angiolo |
| doi_str_mv |
10.1016/j.critrevonc.2016.06.006 |
| dewey-full |
610 |
| title_sort |
metformin use and gynecological cancers: a novel treatment option emerging from drug repositioning |
| title_auth |
Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning |
| abstract |
• Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added. |
| abstractGer |
• Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added. |
| abstract_unstemmed |
• Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U GBV_ILN_11 GBV_ILN_20 GBV_ILN_70 GBV_ILN_100 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2016 GBV_ILN_2048 |
| title_short |
Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning |
| url |
https://doi.org/10.1016/j.critrevonc.2016.06.006 |
| remote_bool |
true |
| author2 |
Biglia, Nicoletta Tana, Roberta Cosio, Stefania Gallo, Martina |
| author2Str |
Biglia, Nicoletta Tana, Roberta Cosio, Stefania Gallo, Martina |
| ppnlink |
ELV019637179 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth |
| doi_str |
10.1016/j.critrevonc.2016.06.006 |
| up_date |
2024-07-06T16:47:32.824Z |
| _version_ |
1803848990405427200 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV040154548</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624071144.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.critrevonc.2016.06.006</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016018000014.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV040154548</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1040-8428(16)30139-1</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Gadducci, Angiolo</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">11</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• Many sentences have been shortened. • A figure on biological effect of metformin was added. • A table with ongoing clinical trials was added.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Endometrial cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemoprevention</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Insulin-like growth factor [IGF]</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AMP-activated protein kinase [AMPK]</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Mammalian target of rapamycin [mTOR]</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Breast cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Metformin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Diabetes</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Insulin</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Ovarian cancer</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Biglia, Nicoletta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Tana, Roberta</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cosio, Stefania</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gallo, Martina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Dettori, D. ELSEVIER</subfield><subfield code="t">miR-214 in stroma cells and tumor progression</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV019637179</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:105</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:73-83</subfield><subfield code="g">extent:11</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.critrevonc.2016.06.006</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_11</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2016</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2048</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">105</subfield><subfield code="j">2016</subfield><subfield code="h">73-83</subfield><subfield code="g">11</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.4002113 |